BACKGROUND Most available data indicates that stenting for unprotected left main coronary artery disease (ULMCA) with drug-eluting stents (DES) is safe and effective. At present, surgery is considered the gold standard for optimal revascularization. The aim of this study was to evaluate the immediate and long term outcome of patients with ULMCA stenosis who underwent percutaneous coronary inter...

OBJECTIVE Coronary artery disease is a significant source of morbidity and mortality in patients with diabetes. Angioplasty has been associated with higher rates of restenosis in patients with diabetes. Numerous studies have been performed to determine whether coronary artery stenting would be useful in decreasing rates of restenosis of coronary vessels in patients with diabetes. This meta-anal...

Percutaneous balloon angioplasty has been found to be useful for the treatment of intracranial atherosclerotic arterial stenosis. Nonetheless, an ongoing risk of this procedure is arterial dissection, which increases the hazards of acute closure, stroke, and restenosis. Stenting of the intracranial vasculature recently has been shown to be feasible in a variety of circumstances. To our knowledg...

Percutaneous balloon angioplasty has been reported to be useful in the treatment of intracranial atherosclerotic arterial stenoses; however, arterial dissection with increased risk of stroke has limited its widespread implementation. Although vascular stenting has improved the outcome of similar procedures in the extracranial vasculature, its intracranial application has been limited by the lac...

BACKGROUND AND PURPOSE We sought to determine the safety of intracranial stenting with respect to subacute stent thrombosis in patients being treated with standardized antiplatelet therapy. METHODS We retrospectively evaluated the outcome of primary intracranial stenting of atherosclerotic stenoses and of stenting in coil embolization procedures in 67 patients. We focused on those cases that ...

BACKGROUND Despite significant improvements in stent platform, currently available bare-metal stents (BMS) are still associated with restenosis. Thin-strut design cobalt-chromium alloys hold the promise of improving results of BMS, especially when implanted with direct technique. We performed an observational study to appraise outcomes of the novel Skylor™ stent, stratifying outcomes according ...

Coronary stent fracture (SF) is a potential cause of failure increasing the risk for in-stent restenosis, thrombosis, target lesion revascularization and major adverse cardiac events. Overall incidence SF ranges from <1.0% up to 18.6% can be found in 60% failed devices. Advanced imaging techniques have improved detection SF. However, defining optimal therapeutic approach towards these comple...

s Gen ard M oard m nd Pr See O A 72-year-old woman with coronary artery bypass graft surgery (CABG) with mitral valve replacement (MVR) using a 27-mm Carpentier-Edwards bioprosthesis (Edwards Lifesciences, Irvine, California) 6 years earlier was referred to our institution with severe, symptomatic prosthetic valve mitral stenosis. Her clinical history was otherwise significant for recent percut...